ICU Medical Outbids Private Equity Firm To Acquire Smiths Medical

 
• By Reed Miller

ICU Medical will pay about $500m in stock, $1.85bn in cash, and assume certain liabilities to acquire the medical division of Smiths Group. Smiths is also eligible for $100m in milestone payments from ICU Medical. The deal is better than the $2.3bn offer Smiths got from a subsidiary of private equity firm TA Associates earlier in August.

Insulin Infusion Pump - Diabetes Icon Set
• Source: Alamy

Smiths Group has agreed to sell Smiths Medical to ICU Medical for up to $2.45bn.

Smiths Medical markets syringe and ambulatory infusion devices, vascular access, and vital care products while ICU Medical focuses on infusion therapy and other drug delivery and monitoring systems

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business